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Abstract 
Mitosis, the accurate segregation of duplicated genetic material into what will become two new 
daughter cells, is accompanied by extensive membrane remodelling and membrane trafficking 
activities. Early in mitosis, adherent cells partially detach from the substratum, round up and 
their surface area decreases. This likely results from an endocytic uptake of plasma 
membrane material. As cells enter cytokinesis they re-adhere, flatten and exhibit an 
associated increase in surface area. The identity of the membrane donor for this phase of 
mitosis remains unclear. Here we show by biochemical and imaging approaches that 
lysosomes undergo exocytosis during mitosis and that this requires the activity of 
phosphatidylinositol 4-kinase-III. Inhibition of lysosome exocytosis leads to mitotic failure in 
a significant proportion of cells suggesting that this facet of lysosome physiology is essential 




not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted July 24, 2018. . https://doi.org/10.1101/375816doi: bioRxiv preprint 
Introduction 
The emergence of complex multicellular organisms including humans has rested upon the 
evolution of mechanisms by which single cells can duplicate themselves to build distinct 
organs and tissues. The process of mitosis in higher organisms is responsible for normal 
growth, development, aging and repair of most body structures and defects during this event 
can lead to disease states including cancer [1]. Understanding how mitosis is controlled is 
therefore fundamental to tackling a number of prevalent human developmental disorders and 
diseases.  
It has long been known that mitosis involves dramatic alterations in cellular morphology and, 
particularly for adherent cell types, there is a weakening in attachment to the extracellular 
matrix on entry in to mitosis. This is accompanied by a significant reduction in plasma 
membrane (PM) surface area that manifests as cell rounding. These morphological changes 
appear intimately linked to activation of specific cell signalling pathways and cytoskeletal 
rearrangements occurring within the cytoplasm [2]. It was originally speculated that changes 
in cell volume and surface area could be achieved through folding and unfolding of the PM 
perhaps into villus like protrusions/invaginations and some cell types may employ this strategy 
[3, 4]. Intuitively it was speculated that an alternative mechanism for dynamic adjustment of 
PM surface area during mitosis could occur through the processes of endo- and exocytosis 
[4]. The first studies examining vesicular trafficking during mitosis identified endocytic 
compartments as potential sources of membrane for surface area expansion late in mitosis [5] 
while later work identified Golgi-derived vesicles as possible mediators of this phenomenon [6]. 
Lysosomes are remarkably versatile intracellular organelles that perform numerous essential 
functions within cells [7]. They are master regulators of cellular metabolism, contribute to 
catabolism of cellular debris, including foreign pathogens, and are central to macro-autophagy 
[8]. In addition lysosomes are important calcium (Ca2+) signalling platforms [9] and can 
facilitate repair of mechanical damage to the PM in most cell types [10]. This latter function of 
lysosomes depends upon their ability to undergo Ca2+-dependent exocytosis at the PM and a 
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combination of lysosomal membrane material and soluble lysosomal hydrolases appear 
important in the process of wound healing [11]. More recently it has been proposed that 
excessive lysosomal exocytosis may in-part be responsible for the enhanced invasiveness of 
cancer cells [12, 13]. In work examining the role of a small Ca2+ binding protein, CaBP7 and 
phosphatidylinositol 4-kinaseIII (PI4K) our laboratory uncovered a potentially unique role for 
lysosomes during mitosis in mammalian cells [14]. We characterised a highly organised and 
temporally coordinated clustering of lysosomes to the site of PM constriction in mitotic cells. 
Inhibition of this clustering, through a PI4K-dependent mechanism, was accompanied by a 
significant increase in mitosis failure. Taken together these observations indicated that the 
spatial distribution of lysosomes had an important functional impact on mitosis progression. 
However, the exact role of lysosomes during mammalian cell division remains unclear. In the 
present study, with the knowledge that mitosis requires membrane remodelling and that an 
organelle(s) with the ability to undergo exocytosis could be important for PM expansion we 
have examined whether lysosomes undergo exocytosis during mitosis. Using a number of 
mammalian cell lines we show, using biochemical assays that track the release of soluble 
lysosomal content into the extracellular space, that there is an increase in lysosome exocytosis 
as cells undergo mitosis. These data were confirmed in Total Internal Reflection Fluorescence 
Microscopy (TIRFM) imaging studies where we monitored coordinated lysosome (organelles 
identified based on their ability to accumulate acidotropic dye but which were negative for 
mannose-6-phosphate receptor) trafficking and fusion events at the site of PM constriction. 
Pharmacological inhibitors targeting the exocytic machinery or PI4K directly induced 
significant mitosis failure suggesting that PI4K-dependent lysosome exocytosis is functionally 
relevant for normal mitosis completion. We speculate that this behaviour of lysosomes could 
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Results 
Lysosomal protein expression and surface appearance is upregulated in mitotic cells which 
exhibit a corresponding increase in lysosomal exocytosis. 
We first examined if there were discernible differences in lysosomal protein expression and 
cellular distribution between asynchronous and chemically synchronised (thymidine-
nocodazole) cells (Fig. 1A). Surface proteins were labelled with a cell-impermeant biotinylated 
cross-linking reagent (Sulfo-NHS-SS-biotin), streptavidin affinity-purified from detergent 
extracted lysates and analysed by Western blotting for the lysosomal membrane protein 
LAMP-1 (Fig. 1A). Densitometry analysis of this data highlighted that intracellular LAMP-1 
protein levels in mitotic cells increase 6.7-fold compared to levels in asynchronous cells. 
(Tubulin loading control normalised, Fig. 1A). In mitotic cells, surface LAMP-1 represented 8% 
of the total LAMP-1 signal (surface + cytosol) in comparison to 0.28% in asynchronous cells. 
As a complimentary method to assess lysosomal protein at the PM we used surface 
immunofluorescence. Due to the difficulty of finding reliable antibodies directed towards 
luminal epitopes of lysosomal proteins, we developed LysopHluorin-mCherry (LpH-mCh, Fig. 
extended view 1A), an mCherry tagged, lysosomally targeted construct derived from the 
previously described Lyso-pHoenix [15]. LpH-mCh contains the CD63 lysosome targeting 
information followed by pHluorin (a pH sensitive ecliptic GFP variant quenched at acidic pH) 
and mCherry (a pH insensitive red fluorophore, pKa ~4.5) such that both tags are located 
within the lysosome lumen. LpH-mCh targets extensively to structures positive for the 
acidotropic dye Lysotracker® but largely negative for mannose-6-phosphate receptor (Fig. 
extended view 1B and C) indicating that LpH-mCh is a lysosome-specific pH sensor. In cells 
expressing LpH-mCh, if a lysosome were to exocytose at the PM then the pHluorin and 
mCherry tags would become accessible at the cell surface to specific antibodies. We used 
mCherry fluorescence to determine LpH-mCh localisation throughout the cell and anti-RFP 
antibody for staining of non-permeabilised cells to detect surface-accessible mCherry protein 
(Fig. 1B). We normalised the surface LpH-mCh signal to total cellular LpH-mCh signal (PM + 
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intracellular) and observed a statistically significant increase in surface LpH-mCh signal in 
mitotic cells (Fig. 1C), consistent with our surface biotinylation data (Fig. 1A).  
Having biochemical and imaging-based evidence that lysosomal membrane protein 
abundance at the PM apparently increased in mitotic cells we next wanted to test if this was 
due to lysosome exocytosis and not biosynthetic trafficking of newly synthesised LAMP-1 to 
lysosomes. The latter interpretation would be unusual since the Golgi apparatus fragments 
early during mitosis [16] precluding synthesis of new secretory pathway proteins and therefore 
would require a novel mechanistic explanation. We measured lysosome exocytosis directly 
using a previously characterised Lucifer Yellow (LY) uptake and secretion assay [10]. For 
these experiments we used BSC-1 cells (African green monkey kidney epithelial cells) since 
HeLa cells have previously been shown to exhibit relatively low levels of lysosome exocytosis 
[10]. LY exocytosis was determined at different time points: immediately (directly following 
release of the second thymidine block in mitotic cells (t = 0 hours)) or at 20 hours following the 
release (t = 20 hours), to permit synchronised cells to undergo a complete round of division. 
Cells arrested in interphase were processed at precisely the same time points however they 
were maintained in the presence of thymidine for the entire experiment. Mitotis- and 
interphase-specific LY release was then calculated as fold changes between the t = 0 hour 
and t = 20 hour time points (Fig. 1D).  Cells demonstrated a significant increase in exocytosis 
during mitosis, from a 0.99-fold increase in interphase to a 1.24 fold at mitosis (Fig. 1D). All 
data were corrected for cell death by examination of cell density in bright-field images (Fig. 
extended view 2). 
Lysosome exocytosis visualised by TIRFM in mitotic cells 
Having acquired data indicating that lysosome exocytosis increases as cells progress through 
mitosis we examined this process at the level of individual exocytic events in live cells using 
TIRFM. In mitotic cells expressing LpH-mCh or loaded with Lysotracker®  we observed a 
remarkable and highly dynamic clustering of lysosomes first to the site of PM constriction early 
in telophase and subsequently to either side of the intercellular bridge (as previously reported 
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using standard confocal microscopy [14]) (Fig. 2A & B and Movies extended view 1,  2 and 3). 
Employing diffusion analysis developed in [6] (see methods) to determine vesicle-PM fusion 
(exocytosis) we demonstrated that lysosomes underwent fusion events consistent with 
exocytosis at the PM in these cells (Fig. 2C and D and Movies extended view 4 and 5). Over 
similar time courses in interphase cells we were unable to observe individual lysosome 
exocytosis events. Examination of TIRFM data showed that we were however able to detect 
numerous docking/undocking like events (movement of lysosomes towards and away from 
the PM) that were not accompanied by exocytosis in both mitotic and interphase cells (Fig. 2E 
and movie extended view 6). In conjunction with diffusion analysis, we used the complimentary 
measurement of pHluorin de-quenching as a readout of lysosome exocytosis at the PM. To 
validate de-quenching as a diagnostic tool we first characterised exocytosis in cells at 
interphase, treated with 10 M ionomycin (Fig. extended view 3). Upon fusion of lysosomes 
with the PM, the organelle lumen and the extracellular space become continuous, resulting in 
lysosomal alkalinisation and a marked increase in pHluorin fluorescence (Fig. 2C and movies 
extended view 4 and 5). Collectively these data show that lysosomes are highly mobile at all 
stages of the cell cycle, cluster at either side of the intercellular bridge at telophase and 
exocytose during mitosis. 
Inhibition of lysosome exocytosis with N-ethylmaleimide or PIK-93 induces mitotic failure 
N-ethylmaleimide is a well-documented inhibitor of vesicular fusion events dependent upon 
the hexameric ATPase NSF [17, 18]. We treated LY loaded cells with 1mM NEM for 15 
minutes and assessed the impact on lysosome exocytosis (Fig. 3A). NEM treatment reduced 
lysosome exocytosis by approximately 40% and this correlated with a complete block on cell 
division monitored in live cell analysis of NEM treated mitotic cells (Fig. 3B). NEM is known to 
disrupt multiple NSF dependent trafficking events and as such is a non-specific inhibitor. 
Based on previous data generated in our laboratory suggesting a role for PI4K in lysosome 
physiology and mitosis we tested the effect of the PI4K inhibitor PIK-93 [19], on lysosome 
exocytosis (Fig. 3C). Although PIK-93 may not be completely specific for PI4K it is 
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considerably more selective than NEM and was used at the published IC50 for PI4K (19 nM) 
which is significantly below the inhibitory concentration for other kinases. PIK-93 treatment of 
cells abolished Ca2+-dependent lysosome exocytosis of the soluble lysosomal hydrolase N-
acetyl -D Glucosaminidase (NAG)[10] (Fig. 3C) and significantly increased the proportion of 
polynucleated cells (Fig. 3F).  Having shown that inhibition of PI4K impairs exocytosis, we 
next examined the effect of PI4K overexpression on lysosomal fusion with the PM. Although 
detection of changes in lysosome exocytosis remained challenging in HeLa cells, 
overexpression of PI4K triggered a surprisingly significant increase in NAG release, further 
reinforcing the involvement of the enzyme in the exocytic process (Fig. 3D). 
In order to test whether lysosomal hydrolases released during exocytosis are required mitosis 
completion we treated cells with the cathepsin inhibitor E64 (Fig. 3E and 3F and Fig. extended 
view 4). These cells exhibited no detectable impairment in mitosis compared with controls. 
Glycyl-L-phenylalanine 2-naphthylamide (GPN) is another reagent that has been used to 
interfere with lysosome function [20, 21]. It is a specific cathepsin C substrate which, once 
cleaved, is osmotically active within the lysosome lumen leading to excessive water 
accumulation and physical swelling/perforation of the organelle. Cells were treated overnight 
with GPN and then fixed for immunofluorescence analysis with an anti-tubulin antibody and 
DAPI staining. In a previous report we described an analysis of mitotic failure based on the 
appearance of cells with 2n copies of the nucleus or an increased frequency of cells connected 
by an intercellular bridge [14]. We used the same approach here to examine the effect of 
inhibiting lysosome activity with GPN. GPN treatment induced a significant increase in the 
proportion of bi-/tetra-nucleate cells and cells connected by a clearly identifiable intercellular 
bridge (Fig. 3E and 3F). Another pharmacological agent suggested to impair lysosome 
function, vacuolin-1, had no effect on mitosis (Fig.3E and 3F) which is consistent with a 
previous report showing that this drug does not inhibit lysosome exocytosis [22].  
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Discussion 
Understanding the regulatory mechanisms that govern mitosis has huge potential impact for 
human health. The Spindle Assemble Checkpoint (SAC) is recognised as the most important 
regulatory mechanism that operates during mitosis [23, 24]. SAC is a valid anti-cancer target 
and a number of currently employed chemotherapeutic agents work by stabilising or 
destabilising the microtubule network (MT) to activate this checkpoint and stall cells 
undergoing division [1, 25]. Blocking mitosis in this way has the immediate effect of halting cell 
proliferation but has an added advantage in that such cells can enter mitotic cell death 
ultimately destroying transformed cells. Drugs such as Taxol (MT stabiliser) and the vinca 
alkaloids (MT destabilsers) have been employed clinically for many decades however they 
have potential off-target effects on normal cells and therefore new generation anti-mitosis 
agents will ideally exhibit greater cancer cell selectivity [1]. One way in which specificity can 
be enhanced is to identify new regulatory inputs required for successful mitosis completion.  
Roles for phosphoinositide metabolism [26, 27], calcium signalling [28] and vesicular 
membrane trafficking [5, 6] during mitosis have been reported although are significantly less 
well understood. Control of membrane remodelling during mitosis is accepted as integral for 
normal cell division and manipulations that prevent cell-rounding place a block on mitosis [5]. 
The underlying cell biology mediating membrane contraction and expansion have been 
investigated in previous studies and it appears that multiple membrane trafficking pathways 
could be involved [5, 6]. These reports provide unique insights into organelle exocytosis during 
mitosis but they do not prove unequivocally that either Golgi vesicles or endosomes are 
essential for normal mitosis.  
In a previous study, we reported a distinct redistribution of lysosomes in mitotic HeLa cells 
which appeared to have functional relevance for mitosis completion [14]. Exocytosis of 
lysosome related organelles is important in a number of professional secretory cell types, 
particularly those of the immune system [29]. In pioneering studies the work of the Andrews 
laboratory described a more general feature of standard lysosomes, present in almost all cell 
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types, to undergo Ca2+-dependent exocytosis in response to PM damage [10, 30]. These 
observations uncovered a previously unknown and unexpected property of lysosomes, which 
has since been implicated in cancer cell migration and drug resistance [12, 13, 31]. It is clear 
that lysosomes serve multiple important functions in cells with increasing attention being paid 
to their influence on cancer cell behaviour.  
In this study we describe how a known lysosome function acts in a hitherto unknown but 
essential area of mammalian cell biology. We have characterised lysosome exocytosis in 
various mammalian cell types undergoing mitosis and show that disruption of this function 
impairs normal mitosis completion. Our data suggest that lysosomes serve a general function 
during mitosis that requires their exocytosis at the cell PM. One interpretation of our results is 
that, under normal conditions, lysosome exocytosis is linked to the PM remodelling, 
particularly membrane expansion, that occurs during telophase in mitotic cells. This is the first 
study to combine biochemical analyses of organelle exocytosis with high resolution imaging 
to describe how lysosomes might contribute additional membrane during mitosis. Lysosome 
exocytosis as a general mechanism for PM wound repair in various cell types was 
characterised over twenty years ago [10]. The prevailing model posited that lysosomal 
membrane was incorporated into the lesion to restore PM integrity [30]. This view has been 
refined by more recent reports showing that soluble lysosomal hydrolases released upon 
lysosome exocytosis are key extracellular factors in PM wound repair [11, 32]. Acid 
sphingomyelinase [32] and the cysteine proteases cathepsin B and L [11] have been shown 
to be required for PM repair. We examined whether the same machinery that is involved in 
PM wound repair also operates during mitosis by treating cells with the cathepsin inhibitor E64 
and assessing the impact on mitosis completion. Since E64 treatment did not inhibit mitosis 
this suggests that the exocytosis of lysosomes during mitosis serves a mechanistically distinct 
function from that which operates during PM wound repair which we interpret as membrane 
donation.  
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Lysosome exocytosis during mitosis is also unique in that it is a PI4K dependent process. 
PI4K is responsible for generating phosphatidylinositol-4-phosphate, a fusogenic lipid, and 
has a well-documented activity in the biogenesis of anterograde transport vesicles at the 
Trans-Golgi Network [33]. A previous study characterised a biochemically distinct pool of PI4K 
on lysosomes [34] and our observations indicate that a potential function of the kinase on 
these organelles is to prime them for exocytosis at the PM. The data presented here are 
consistent with our previous work where we demonstrated that expression of CaBP7, a PI4K 
inhibitor, disrupts lysosome clustering and inhibits mitosis [14]. Interestingly, the effect of PIK-
93 observed in this study was larger in NRK cells compared with HeLa cells which may reflect 
a heightened sensitivity to the drug of cells exhibiting higher levels of Ca2+-stimulated 
lysosome exocytosis. This suggests that PI4K has a key role in lysosome function during 
mitosis in mammalian cells and that it is required for Ca2+-dependent exocytosis. The role of 
PI4K in lysosome exocytosis may not be restricted exclusively to mitosis and could be required 
for exocytosis of these organelles more generally, including during PM wound repair, however, 
to date, this possibility has yet to be investigated.  
Collectively, our data highlight a novel role for PI4K in lysosome exocytosis, a process that 
represents a potentially new regulatory input controlling mitosis progression, and which may 
offer an additional means to enhance the specificity in targeting rapidly proliferating cells.  
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Material and methods 
Cell culture 
HeLa, HEK293T and NRK-49F cells were maintained in HN media (DMEM supplemented with 
10% (v/v) Foetal Bovine Serum (FBS), 1% (v/v) non-essential amino acids (NEAAs) and 1% 
(v/v) penicillin/streptomycin (P/S). BSC-1 cells were obtained from ATCC and maintained in 
EMEM supplemented with 10% (v/v) FBS, 1% (v/v) NEAAs and 1% (v/v) P/S. All cells were 
cultured at 37°C, 95% (v/v) air/5% (v/v) CO2. 
Cloning of LpH-mCh 
LysopHluorin-mCherry (LpH-mCh) was generated by PCR amplification of the CD63-pHluorin 
domain of pCMV-lyso-pHoenix (from Addgene clone 70112; forward primer (NheI): 5’-
CTGCTAGCATGGCGGTGGAAGGAGGAATG-3’; reverse primer (BamHI): 5’-
CTGGATCCTTTTTGTATAGTTCATCCATGCCATG-3’). The fragment was digested with 
BamHI HF and NheI HF (NEB) and ligated into the pmCherry-N1 vector (Clontech) using T4 
DNA ligase (NEB). Recombinant plasmids were verified by DNA sequencing (Source 
Bioscience, UK). Correct expression of LpH-mCh in HeLa cells was verified by Western blot 
and immunofluorescence analysis. 
Generation of pHIV-LpH-mCh and a LpH-mCh stable NRK cell line using lentivirus 
pHIV-dTomato (Addgene) was digested with XmaI and ClaI (NEB) to excise the dTomato 
fragment. The LpH-mCh coding sequence was amplified by PCR using primers designed for 
In-Fusion® HD Cloning, so that the resulting fragment shared 15-bp homology with the pHIV 
vector (forward primer: 5’-TTCTAGAGTACCCGGATGGCGGTGGAAGGAGGAATG-3’; 
reverse primer: 5’-AGGTCGACGGTATCGCTTGTACAGCTCGTCCATGCC-3’).  
XmaI/ClaI Digested pHIV-dTomato and LpH-mCh PCR product were combined using In-
Fusion® HD enzyme (100ng linearised pHIV, 1l PCR product, 2l enzyme; reaction allowed 
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for 15 min at 50°C). Recombinant LpH-mCh plasmid was amplified by standard techniques 
and verified by DNA sequencing (Source Bioscience, UK). 
HEK293T cells were grown in 10 cm cell culture dishes to 80% confluence and transfected 
with lentiviral components and pHIV-lpH-mCh using Lipofectamine® 2000 (Thermo Fisher 
Scientific) according to manufacturer’s instructions. pMDLg/pRRE was a gift from Didier Trono 
(Addgene plasmid # 12251), pRSV-Rev was a gift from Didier Trono (Addgene plasmid # 
12253) and pCMV-VSV-G was a gift from Bob Weinberg (Addgene plasmid # 8454). Briefly, 
20 g pHIV-lpH-mCh, 10 g pMDLg/pRRE, 5 g pRSV-Rev and 6 g pCMV-VSV-G were 
added to 100 l Lipofectamine® 2000 in Opti-MEMTM (ThermoFisher Scientific). The solution 
was incubated for 20 min at room temperature and 2 ml was added dropwise onto HEK293T 
cell medium. The virus-containing medium was collected 48 hours post-transfection and 
centrifuged for 15 min at 1,000 rpm. The supernatant was filtered through a 0.45 µm filter 
membrane and mixed with fresh medium at a 1:1 ratio. The virus solution was used to infect 
NRK cells to generate a stable cell line expressing LpH-mCh. Expression of LpH-mCh was 
verified by confocal imaging and Western blotting.  
Cell Synchronisation 
Cells were first arrested at interphase with 2 mM thymidine for a minimum of 20 hours, 
released from their block with 25 µM deoxycytidine for 3 to 6 hours and blocked again by 2 
mM thymidine or 35 ng/ml nocodazole (pro-metaphase block) for 12 to 24 hours. Subsequently 
cells were either maintained in their block or released with 25 µM deoxycytidine. Prior to all 
releases, cells were washed 5 times with 10 ml fresh culture medium.  
Biotinylation of cell surface proteins 
Synchronous (thymidine-nocodazole treated) and asynchronous HeLa cells were grown to full 
confluence on 10 cm circular cell culture dishes. Synchronised cells were washed five times 
with 10 ml HN media to release them from the block and incubated for 1 hr at 37oC in a tissue 
culture incubator. The culture media was removed from both populations and cells washed 
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with 10 ml of ice-cold phosphate buffered saline (PBS). Cells were gently detached using a 
cell scraper, transferred to a 15 ml sterile falcon tube and pelleted by centrifugation. Cell 
pellets were gently resuspended in 1 ml ice-cold PBS supplemented with 0.5 mg/ml EZ-link 
Sulfo-NHS-SS-biotin (ThermoFisher Scientific) and incubated on a rotator at 4oC for 30 min. 
Cells were collected by centrifugation and washed once with 1ml ice-cold PBS. Excess 
unreacted Sulfo-NHS-SS-biotin was quenched by incubation of cells with 1 ml 50 mM NH4Cl 
in PBS for 30 min on ice. Cells were pelleted by centrifugation (1 min/1000 rpm in a refrigerated 
microfuge cooled to 4oC) and washed three times with 1 ml ice-cold PBS. Cells were lysed in 
1 ml ice-cold PBSL (PBS supplemented with: 0.1% (w/v) sodium dodecyl sulfate (SDS), 1% 
(v/v) NP-40 and 1% (v/v) Proteoloc protease inhibitor cocktail (Expedeon)) and incubation on 
a rotator at 4oC for 1 hr. Samples were centrifuged at 13,000rpm, 4oC for 5 min and the 
supernatants applied to 100l of Ultralink streptavidin agarose resin (ThermoFisher Scientific) 
that had been equilibrated by washing three times with 1 ml PBSL. Samples were incubated 
on a rotator at 4oC for 1hr, streptavidin resin collected by centrifugation (13,000rpm, 4oC, 1 
min) unbound material removed to a clean Eppendorf tube (non-surface accessible protein 
fraction), resin washed five times with 1 ml ice cold PBS and bound proteins extracted by 
boiling in 100l dissociation buffer (10% (w/v) sucrose, 10% (v/v) glycerol, 4% (w/v) SDS, 1% 
(v/v) -mercaptoethanol, 125 mM HEPES (pH 6.8), 2mM EDTA, 0.05 mg/ml bromophenol 
blue) surface accessible protein fraction).  
SDS-PAGE and Western blotting 
Proteins were resolved on 4-12% Novex NuPage™ Bis-Tris SDS-PAGE and transferred onto 
nitrocellulose membranes. Filters were incubated with blocking solution (BS: PBS containing 
3% (w/v) dried skimmed milk powder) for 1 hour at room temperature. Next, membranes were 
incubated for 1 hour at room temperature with mouse monoclonal anti-LAMP1 (Santa Cruz; 
1:500 dilution) and rabbit anti-β-tubulin (Abcam; 1:1000 dilution) diluted in BS. Membranes 
were washed 3 times in PBS supplemented with 0.05% (v/v) Tween-20 (PBST), twice with 
PBS alone and then incubated with goat anti-rabbit and anti-mouse HRP-conjugated 
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secondary antibodies (Sigma, 1:500 dilution in BS) for 1 hour at room temperature. 
Membranes were then washed three times with PBST and twice with PBS, before addition of 
equal volumes of enhanced chemiluminescence reagents (Clarity, Biorad). Blots were 
subsequently developed and imaged using a ChemiDoc-XRS system (BioRad). Densitometry 
of gel images was performed with ImageJ. 
Immunofluorescence for cytokinesis and polynucleate cell count 
HeLa and NRK cells were grown on 13 mm diameter glass coverslips. Cells were washed 3 
times in PBS and fixed in 4% (w/v) formaldehyde (Sigma) in PBS for 6 min at room 
temperature. Cells were washed again in PBS and permeabilised with 0.5% (v/v) Triton-X in 
PBS for 6 min at room temperature. Following permeabilisation, cells were washed again and 
blocked for 1 hour at room temperature in 5% (w/v) bovine serum albumin (BSA) in PBS (BSS). 
Next, cells were incubated in mouse monoclonal anti-tubulin antibody (Abcam DM1A; 1:500 
dilution in BSS) for 1 hour at room temperature. Subsequently cells were washed thoroughly 
in PBS and further incubated with goat anti-mouse Alexa 488 conjugated secondary antibody 
(1:500 in BSS, Life Technologies) for 1 hour at room temperature. Cells were washed again 
in PBS, coverslips air dried and mounted onto glass slides using ProLongTM Gold Antifade 
glycerol containing DAPI (ThermoFisher Scientific).  
Surface staining 
Cells were kept on ice at all times and all reagents were maintained at 4°C throughout the 
whole procedure to inhibit the endocytic process. LpH-mCh- stable NRK cells grown onto 13 
mm diameter glass coverslips were washed with PBS and incubated with rabbit polyclonal 
anti-RFP antibody (a kind gift from Prof Ian Prior, University of Liverpool, 1:500 dilution in 1% 
(w/v) BSA in PBS for 30 min). Following incubation with primary antibody, cells were 
thoroughly washed in PBS and further incubated for 30 min with goat anti-rabbit Alexa 405-
conjugated antibody (1:500, Life Technologies) in 1% (w/v) BSA in PBS. After final PBS 
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washes, cells were fixed in 2% (w/v) formaldehyde in PBS for 6 min and mounted onto glass 
slides using ProLong TM Gold Antifade glycerol (ThermoFisher Scientific). 
Lucifer Yellow (LY) assay 
Cells were incubated in culture medium supplemented with 1 mg/ml LY carbohydrazide (CH)  
dipotassium salt (Santa Cruz) for 4 hours or overnight, at 37°C, 95% (v/v) air/5% (v/v) CO2, 
washed 3 times in PBS and chased in fresh culture medium for a minimum of 2 hours at 37°C, 
5% (v/v) CO2. Cells were subsequently lysed and the incubation buffer collected as described 
in Cell lysis and media collection for biochemical assays. LY fluorescence was measured in 
the incubation buffer/cell lysate with excitation at 428 nm/emission at 536 nm wavelengths 
using a Jasco FP-6300 spectrofluorimeter.  
Cell lysis and media collection for biochemical assays 
Cell incubation media were collected and stored on ice. All reagents and cells were maintained 
at 4°C throughout the lysis process. Cells were washed twice in PBS and incubated on ice on 
a rocking platform with RIPA buffer (ThermoScientifcTM) for 5 min. They were subsequently 
scraped from culture dishes and an equal volume of ice cold PBS added. Cellular debris were 
pelleted by centrifugation for 15 min at 13,000 rpm and the clarified lysates transferred to fresh 
tubes.  
N-Acetyl-β-D-Glucosaminidase (NAG) assay  
Cells were subsequently lysed and the incubation buffer collected as described in Cell lysis 
and media collection for biochemical assays. Collected incubation buffers/cell lysates were 
incubated for 15 minutes to 1 hour at 37°C, 95% v/v air/5% v/v CO2 with 3 mM 4-nitrophenyl 
N-acetyl-β-D-glucosaminide, a NAG substrate, dissolved in 0.09 M citrate buffer solution (pH 
4.5). The pH of the solution was systematically verified using Fisherbrand pH indicator paper 
sticks prior to NAG reaction. The reaction was stopped by adding 0.4 M sodium carbonate 
(pH 11.5). The product of the NAG substrate hydrolysis, p-nitrophenol, ionised upon addition 
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of stop solution, was measured colorimetrically at 405 nm using a FLUOstar Omega 
Microplate Reader (BMG LABTECH). 
Cell transfection 
All transfections were performed using Promofectin reagent (PromoKine) according to 
manufacturer’s instructions. Briefly, cells were cultured on 35 mm diameter MatTek glass 
bottom microscopy dishes or 13 mm diameter coverslips until they reached 50% confluence. 
Plasmid DNA (3 g/MatTek dish, 1 g/13 mm diameter coverslip) was mixed with 6 l 
(MatTek) or 2 l (coverslip) of Promofectin in serum-free RPMI (50 l/g DNA). The 
DNA/Promofectin solution was incubated for 20 minutes at room temperature then added 
dropwise to cells. Cells were assayed 24-48 hrs post-transfection.  
Imaging 
Confocal imaging of fixed cells was performed on a Zeiss LSM 800 Airyscan microscope 
equipped with a Zeiss AxioObserverZ1, a 63x/1.4 Plan-Apochromat oil immersion objective 
and diode lasers as excitation light source (488 nm for pHluorin and Alexa 488, 405 for DAPI 
and Alexa 405 and 561 nm for mCherry). Emitted light was collected through Variable 
Secondary Dichroics (VSDs) onto a GaAsP-PMT detector. 
TIRF imaging was performed on a 3i Marianas spinning-disk microscope equipped with a 
100x/1.46 Alpha Plan-Apochromat oil objective, a Zeiss AxioObserver Z1, a 3i laserstack as 
excitation light source (488 nm for pHluorin and 561 nm for mCherry and Lysotracker® red) 
and a TIRFM module. Emitted light was collected onto a CMOS camera (Hamamatsu, ORCA 
Flash 4.0) through quadruple bandpass. Live cells were maintained at 37 °C, 5 % CO2 (OKO 
lab incubation chamber).  
Slidebook and Zen software suites were used for image acquisition. Images were processed 
and analysed using Fiji.    
Statistical analysis 
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted July 24, 2018. . https://doi.org/10.1101/375816doi: bioRxiv preprint 
Unless stated otherwise experiments were performed at least in triplicate (N = 3) and results 
are expressed as mean ± S.E.M. When applicable, the number of cells (n) is stated in the 
figure legends. All statistical analyses were performed on GraphPad Prism 6 software. 
Students’ unpaired t-tests was used for statistical comparison between groups, as indicated 
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Figure legends 
Fig. 1. Cellular expression and plasma membrane residency of a lysosomal membrane protein 
increases during mitosis. A) Western blot analysis of surface and cytosol fractions revealed 
increased expression of LAMP-1 in the cytosol of mitotic cells and its appearance at the 
surface of synchronised HeLa cells but not at the surface of interphase cells. The surface 
accessible protein fraction of synchronous (sync) and asynchronous (async) cells was 
captured by surface biotinylation and streptavidin affinity purification. Post-strepavidin cell 
lysates (non-surface, cytosol) were also prepared. Cytosolic LAMP-1 signals were normalised 
to a -tubulin loading control signal from the same samples. Predicted sizes: 120 kDa 
(LAMP1), 50 kDa (β-tubulin). B) Confocal images show deconvoluted middle sections at 
interphase and cytokinesis. HeLa cells were transfected with LpH-mCh. The luminal part of 
the construct (mCherry, red) was detected on the cell surface using rabbit anti-RFP (blue) and 
goat anti-rabbit Alexa 405 conjugated antibodies, prior to cell fixation without cell 
permeabilisation. Scale bars: 10 m. C) Quantification of data from (B). The fluorescence of 
RFP at the membrane expressed as % of total cellular RFP fluorescence is increased in the 
late stages of cell division, compared to HeLa cells in interphase. *p = 0.0446; n = 5 cells in 
interphase; n = 4 cells in late telophase/cytokinesis.  D) Lucifer yellow (LY) secretion increases 
during mitosis in BSC-1 cells. All cells were synchronised using a double thymidine block and 
loaded with 1mg/ml LY (12-hour pulse and 2-hour chase). After the second thymidine 
treatment, cells were maintained in thymidine (interphase) or released from the block (mitosis). 
LY secretion was assessed immediately after release (time = 0 hours) and 20 hours post-
release in both mitotic and interphase cell populations. Data were corrected for cell death 
using bright field live cell images (Fig. extended view 2). The results are depicted as LY fold 
changes, from 0 to 20 hours after release.  Results shown as mean ± S.E.M. Unpaired student 
t-test *p = 0.0494, N = 3. 
Fig. 2. TIRFM analysis of lysosomes located near the plasma membrane which localise to the 
site of cytoplasmic constriction and undergo exocytosis during mitosis. A & B) Cells were 
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loaded with 50 nM Lysotracker ® red for 30 minutes and imaged at a rate of 1 frame every 30 
seconds (BSC-1 cells; A) or every 2 seconds (NRK cells; B) showing the clustering of 
lysosomes during mitosis. C) Example of lysosome exocytosis in a LpH-mCh-stable NRK cell 
undergoing cytoplasmic constriction (late telophase/early cytokinesis). The white square (and 
zoomed view) represents the exocytosing lysosome analysed in the accompanying graphs. 
The top graph shows the diffusion analysis along a line (black) drawn across the lysosome. 
The second graph illustrates the sharp and simultaneous increase in both pHluorin and 
mCherry fluorescence upon exocytosis in a region of interest drawn around the same 
lysosome. LpH-mCh-NRK cell was imaged every 0.5s. D) Zoomed view of a lysosome loaded 
with Lysotracker ® (highlighted by the yellow square). The time indicates the time for the 
lysosome to dock, fuse with the PM and diffuse Lysotracker ® fluorescence in the extracellular 
space. The graph depicts the spreading of the fluorescence across the black line. E) Diffusion 
analysis of a Lysotracker ® -loaded lysosome moving in close proximity to cytoplasmic face 
of the PM (docking-undocking) during interphase. NRK cell was imaged every 2 s. The 
lysosome analysed is highlighted by the yellow square and represented in the zoomed view. 
The graph demonstrates fluorescence does not spread across the line drawn across the 
lysosome (blue line) as the width of fluorescence remains unchanged. The time specifies the 
duration of the lysosome vertical movement, which is shorter than fusion duration. Time 
indicated as hr:min:sec. White scale bars: 10 m. 
Fig. 3. Lysosome exocytosis requires PI4K and is essential for mitosis completion in 
mammalian cells. A) NEM reduces LY release in BSC-1 cells. Cells were incubated with 
1mg/ml LY for 4 hours, washed and chased for a further 2 hours to permit accumulation in 
lysosomes. Cells were subsequently treated with 1 mM NEM (or 0.25% (v/v) Ethanol, vehicle 
control) for 15 min. LY secretions were then measured and expressed as % of total cellular 
LY; *p = 0.0370, N = 3. B) NEM treatment blocks mitosis in BSC-1 cells. Cells were treated 
with 1 mM NEM (or 0.25% (v/v) Ethanol, vehicle control) for 15 min and imaged using a 3i 
spinning disk microscope. The proportion of cells reaching mitosis completion was counted 
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and expressed as % of total cell numbers in each field of view. *p = 0.0130, n(control) = 247 
cells, n(NEM) = 217 cells, N = 3. C) PI4K inhibition by PIK93 decreases Ca2+-dependent 
exocytosis in NRK cells. Cells were incubated with 19 nM PIK93 (or 0.1% (v/v) DMSO, control) 
for 40 minutes in the presence or absence of 10 M ionomycin for 10 min. NAG lysosomal 
enzyme secretion was measured in the incubation media and in the cell lysates and calculated 
as % of total cellular NAG. *p = 0.0149, N = 3. D) Overexpression of PI4K enhances lysosome 
exocytosis. Lysosomal NAG release was assessed in HeLa cells transfected with HA-PI4K 
(control: transfection reagent only). *p = 0.0356, N = 3. E) and F) Cells were treated for 40 min 
with 19 nM PIK93 (or 0.1% (v/v) DMSO, control) or overnight with 1 μM Vacuolin (or 0.1 % 
DMSO, control), 50 μM GPN (or 0.1% (v/v) DMF, control) or 100 μM E64 (or untreated, 
control). Cells were then fixed, permeabilised and immunostained with anti-tubulin antibody 
and DAPI. The proportion of cells at cytokinesis (E) and bi/tetranucleate cells (F) were counted 
in each condition. Results represent fold changes under treatment with the drugs compared 
to their respective vehicle controls. The proportion of bi/tetranucleate NRK cells is significantly 
raised under treatment with PIK93 (**p = 0.0031, n(control) = 942 cells, n(PIK93) = 1310 cells, 
N = 6). No significant mitosis defects were observed in NRK cells treated with the lysosomal 
cysteine protease inhibitor E64 (n(control) = 521 cells, n(E64) = 619 cells, N = 6). GPN but not 
Vacuolin triggered significant mitosis defects in HeLa cells (*p(vacuolin) = 0.0298, **p(GPN, 
cytokinesis) = 0.006, **p(GPN, polynucleated) = 0.001, n(vacuolin) = 1560 cells (n(control) = 
1250 cells) n(GPN) = 1648 cells (n(control) = 1322 cells), N(cytokinesis) = 12, 
N(polynucleated) = 8. Statistical significance was calculated using unpaired student t-test and 





not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted July 24, 2018. . https://doi.org/10.1101/375816doi: bioRxiv preprint 
Fig. 1. 
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Extended view figure legends 
Fig. extended view 1. Architecture and cellular localisation of LysopHluorin-mCherry (LpH-
mCh) in mammalian cells. A) Schematic representation of the LpH-mCh expression construct. 
CD63 targeting motif for localisation to lysosomes; pHluorin, a pH sensitive GFP-variant, 
quenched at acidic pH. The luminal mCherry tag, fluorescent at acidic pH, allows visualisation 
of the construct at all times. B) LpH-mCh (red) colocalises extensively with cellular organelles 
that accumulate the acidotropic dye Lysotracker® (blue). Regions of colocalisation appear 
pink in overlay images. C) LpH-mCh (red) exhibits limited colocalisation with endogenous 
mannose-6-phosphate receptor (-M6PR antibody, blue). Scale bars 10 m. 
Fig. extended view 2. Assessment of BSC-1 cell death in time course LY assay. Bright field 
imaging was performed on a Zeiss apotome widefield system at a rate of 1 frame every 5 min. 
A) Representative images from each condition in one triplicate. The time between the start of 
release from the last block in mitotic cells/the end of thymidine block in interphase cells and 
the start of lucifer yellow assay is indicated at the side of each panel. Imaging time is shown 
as hr:min; scale bars 50 m. B) Cell death was plotted as % of total cell number in a bright-
field area of view for all conditions and subsequently subtracted from LY secretion data. 
Unpaired student t-test, data shown as mean ± S.E.M, N = 3. 
Fig. extended view 3. Characterisation of lysosome exocytosis in LpH-mCherry stable NRK 
cells. A) Representative TIRF data from a cell following treatment with 10 M ionomycin and 
imaged immediately at a rate of 1 frame every 500 ms. A region of interest at the site of 
lysosome exocytosis was selected (white circle and expanded region of interest in (B)) and 
the fluorescence intensity of mCherry (fmCherry, red) and pHluorin (fLpH, green) measured. 
B) Exocytosis of lysosomes expressing LpH-mCherry at the PM was characterised by a de-
quenching of pHluorin fluorescence which undergoes a sharp increase in intensity upon 
fusion, coincident with an increase in mCherry fluorescence (graph of normalised fluorescence 
intensity versus time and picture at frame t = 14.5 sec where a yellow signal is visible due to 
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fluorescence in both mCherry and pHluorin channels). Diffusion of lysosomal membrane 
content in the plane of the PM is rapid and the yellow fluorescence signal is lost within 4s of 
exocytosis (t = 18.5 sec). The time on the zoomed pictures indicates the elapsed imaging time 
in sec. Scale bar 10 m. 
Fig. Extended view 4. Inhibition of lysosomal cathepsins by E64 has no effect on HeLa cell 
mitosis. Cells were treated overnight with 100 μM E64 (or untreated, control), fixed and 
permeabilised. The proportion of cells linked by an intercellular bridge during cytokinesis (A) 
and the number of bi/tetranucleate cells (B) were assessed by spinning disk confocal 
microscopy using an anti-tubulin antibody (green) and DAPI (blue). n(control) = 960 cells, 
n(E64) = 909 cells, N = 6. The arrow indicates the position of the intercellular bridge. Unpaired 
student t-tests; results shown as ± S.E.M, ns: not significant. Scale bars in representative 
confocal sections: 10 μm. 
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Fig. extended view 2. 
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Fig extended view 4. 
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